Opsona Therapeutics Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Out of Business

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Liquidation

Opsona Therapeutics General Information

Description

Developer of novel therapeutic approaches designed to focus on the treatment of autoimmune or inflammatory diseases and cancers. The company's approach targets the innate immune system associated with a wide range of major human diseases, including autoimmune and inflammatory diseases, transplant rejection, cancer, diabetes, Alzheimer's disease and atherosclerosis, enabling healthcare providers to cure their patients.

Contact Information

Website
www.opsona.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Second Floor, Ashford House
  • Tara Street
  • Dublin 2
  • Ireland
+353 (01)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Second Floor, Ashford House
  • Tara Street
  • Dublin 2
  • Ireland
+353 (01)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Opsona Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Bankruptcy: Liquidation 13-Jan-2019 Completed Bankruptcy: Liquidation
9. Later Stage VC (Series F) 26-Aug-2018 Completed Clinical Trials - Phase 2
8. Later Stage VC 03-Feb-2017 Completed Clinical Trials - Phase 2
7. Secondary Transaction - Private Completed Generating Revenue
6. Later Stage VC 01-Mar-2014 Completed Generating Revenue
5. Later Stage VC (Series C) 02-Oct-2013 Completed Generating Revenue
4. Grant 06-May-2011 Completed Generating Revenue
3. Early Stage VC (Series B) 19-May-2009 Completed Startup
2. Early Stage VC (Series A) 24-Feb-2005 $8.12M $8.12M Completed Product Development
1. University Spin-Out 01-Jan-2004 Completed Startup
To view Opsona Therapeutics’s complete valuation and funding history, request access »

Opsona Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel therapeutic approaches designed to focus on the treatment of autoimmune or inflammatory diseases and
Biotechnology
Dublin, Ireland
9 As of 2023

Utrecht, Netherlands
 

Copenhagen, Denmark
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Opsona Therapeutics Competitors (55)

One of Opsona Therapeutics’s 55 competitors is AM-Pharma, a Venture Capital-Backed company based in Utrecht, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AM-Pharma Venture Capital-Backed Utrecht, Netherlands
Galecto Formerly VC-backed Copenhagen, Denmark
Spero Therapeutics Formerly VC-backed Cambridge, MA
SAGE Therapeutics Formerly VC-backed Cambridge, MA
Tricida Formerly VC-backed Sacramento, CA
You’re viewing 5 of 55 competitors. Get the full list »

Opsona Therapeutics Patents

  • 53

    Total Documents Applications and Grants

  • Total Patents Families

  • 21

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Opsona Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160355601-A1 Methods and compositions for the treatment of pancreatic cancer Inactive 19-Oct-2012
EP-2909236-B1 Methods and compositions for the treatment of pancreatic cancer Active 19-Oct-2012
EP-2909236-A1 Methods and compositions for the treatment of pancreatic cancer Active 19-Oct-2012
EP-2722342-A1 Methods and compositions for the treatment of pancreatic cancer Inactive 19-Oct-2012
GB-201205633-D0 Toll-like receptor 2 binding epitope and binding members thereto Inactive 30-Mar-2012 C07K14/70596
To view Opsona Therapeutics’s complete patent history, request access »

Opsona Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Opsona Therapeutics FAQs

  • When was Opsona Therapeutics founded?

    Opsona Therapeutics was founded in 2004.

  • Where is Opsona Therapeutics headquartered?

    Opsona Therapeutics is headquartered in Dublin, Ireland.

  • What is the size of Opsona Therapeutics?

    Opsona Therapeutics has 9 total employees.

  • What industry is Opsona Therapeutics in?

    Opsona Therapeutics’s primary industry is Biotechnology.

  • Is Opsona Therapeutics a private or public company?

    Opsona Therapeutics is a Private company.

  • What is Opsona Therapeutics’s current revenue?

    The current revenue for Opsona Therapeutics is .

  • How much funding has Opsona Therapeutics raised over time?

    Opsona Therapeutics has raised $115M.

  • Who are Opsona Therapeutics’s competitors?

    AM-Pharma, Galecto, Spero Therapeutics, SAGE Therapeutics, and Tricida are some of the 55 competitors of Opsona Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »